The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
SandboxAQ, a startup drawing on quantum computing techniques to develop quantitative artificial intelligence models for ...
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
It was joined by Alphabet and GV, the search giant’s startup investment arm. Isomorphic Labs is led by Chief Executive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results